Press Releases
ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program
read more ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program
ProBioGen and TEVA sign License Agreement on Human Artificial Lymph Node Technology
read more ProBioGen and TEVA sign License Agreement on Human Artificial Lymph Node Technology
Chiome Bioscience Selects ProBioGen for GlymaxX® Antibody Manufacturing Program
read more Chiome Bioscience Selects ProBioGen for GlymaxX® Antibody Manufacturing Program
ProBioGen in Biosimilar Deal with Bio Farma Indonesia
read more ProBioGen in Biosimilar Deal with Bio Farma Indonesia
Zymeworks Contracts ProBioGen for Bi-specific GlymaxX® Antibody Cell Line Development
read more Zymeworks Contracts ProBioGen for Bi-specific GlymaxX® Antibody Cell Line Development